TrialInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2023

Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumonia.

Mahoko Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.